A new weapon in the fight against osteoarthritis?
Researchers at ETH Zurich, Empa and the Norwegian research institute SINTEF are pursuing a new approach to treating osteoarthritis. This is based on a polysaccharide, a long-chain sugar molecule, originating from brown algae. When chemically modified, this “alginate” reduces oxidative stress, has an anti-inflammatory effect in cell culture tests and suppresses the immune reaction against cartilage cells, thereby combating the causes of arthritis. The research is, however, still in its infancy.
Osteoarthritis is the most-widespread joint disease, with around 90 percent of all people over 65 being affected to varying degrees, but this degenerative disease is also widespread amongst younger people. In arthritis, the cartilage in the joint, a type of protective layer on bones that “lubricates” the joint, degenerates over time. This can be extremely painful for sufferers, because inflammatory reactions are associated with cartilage degeneration. In the later stages of the disease, bones are no longer adequately protected and can directly rub against each other.
Osteoarthritis can affect all joints in the body, but most often affects the knee joint, hip joint and fingers. The disease has been considered incurable until now. Current treatment methods, such as anti-inflammatory drugs and painkillers, mainly address the symptoms. Often, the only remaining option is an operation to replace the affected joint with an artificial one.
Initial research results are encouraging
In laboratory tests, the team led by ETH researcher Marcy Zenobi-Wong and Empa researcher Katharina Maniura has now succeeded, together with SINTEF in Norway, in identifying a substance with the potential to halt cartilage degeneration in joints. This substance is the polysaccharide alginate extracted from the stems of brown algae – or more precisely cuvie (Lat. Laminaria hyperborea), which is similar to specific extracellular biomolecules in cartilage. The researchers chemically modified the alginate with sulfate groups and then added it in dissolved form to cell cultures to examine the reaction of various cell types to the modified polysaccharide. This revealed that alginate sulfate can significantly reduce oxidative stress, which is a frequent cause of cell damage or even cell death, and the more sulfate groups attached to the alginate molecule, the greater this reduction.
Alginate sulfate was also able to suppress the inflammatory reaction, again depending on the number of sulfate groups, and was able to down-regulate the expression of genes that trigger an inflammatory reaction in both human cartilage cells, known as chondrocytes, and in macrophages, the “scavenger cells” of our immune system. The algal molecules should therefore slow down cartilage degeneration. “The hope is that they can even stop this degeneration,” says Empa researcher Markus Rottmar.
Further research work necessary
The alginate sulfates have so far only been tested in vitro, i.e. in the laboratory with cell cultures. However, the encouraging results mean that research will now continue. The next stage is to test the substances on animals. If this is also successful, clinical trials can then be conducted on people. These tests are, however, laborious and time-consuming. If everything were to work perfectly, it would still be a few years before arthritis patients could be treated with alginate sulfate.
Learn more: Treating arthritis with algae
The Latest on: Osteoarthritis
- Pricey stem cell treatments are being offered at more clinics. They may not be FDA-approved.on November 19, 2019 at 11:25 am
Meniscus and cartilage injuries, peripheral neuropathy, rotator cuff problems, sciatica, herniated discs, carpal tunnel, osteoarthritis. The pain of these ailments can be eased by stem cell treatments ...
- Joint Pain Treatment: 3 Best Supplements For Articulation Problemson November 19, 2019 at 3:30 am
Suffering from pain in the joints can sometimes become unbearable. While joint pains may have come as a result of an accident, many of them are symptoms of chronic illnesses, including osteoarthritis.
- Dealing with osteoarthritison November 18, 2019 at 3:07 pm
As the most common form of arthritis, osteoarthritis (OA) affects 20% of people over the age of 50 globally. Also known as degenerative joint disease, OA can also affect people in their 20s or 30s.
- Seven approaches you may not have thought of to treat osteoarthritison November 18, 2019 at 5:20 am
As many as 8.75 million in the UK have been diagnosed with osteoarthritis, but plenty of others have not yet seen a doctor. No-one wants to have their lifestyle curtailed so here are a few different ...
- How to treat hip osteoarthritison November 15, 2019 at 11:07 pm
Osteoarthritis, sometimes called "wear and tear" arthritis, is a common degenerative condition. Doctors can treat osteoarthritis with medication and surgery. People can also manage their symptoms with ...
- Osteoarthritis Care Gets a Makeover With New Recommendationson November 15, 2019 at 1:25 pm
Osteoarthritis (OA) is the most common form of arthritis. Known as the “wear and tear” disease, this degenerative joint condition affects more than 30 million adults nationwide, according to the ...
- 2019 Osteoarthritis Therapeutics Market- Sanofi, Horizon Therapeutics, Johnson & Johnson, GlaxoSmithKline Plc and moreon November 14, 2019 at 1:42 am
Nov 14, 2019 (The Expresswire) -- Osteoarthritis Therapeutics Market Report including industry Overview, Country Analysis, Key Trends, Key Retail Innovations, Competitive Landscape and Sector Analysis ...
- Pain Management: Losing your grip with osteoarthritison November 11, 2019 at 3:54 pm
Like Kathy, about 75 percent of women and 50 percent of men are affected with nodal osteoarthritis by age 70. A common time for osteoarthritis to emerge is around menopause, suggestive of a possible ...
- Can-Fite Obtains Patent For Treatment Of Osteoarthritis In Mammalson November 11, 2019 at 10:39 am
Israeli biotechnology company Can-Fite BioPharma Ltd. (NYSE: CANF) said Monday that its drug candidate Piclidenoson for the treatment of osteoarthritis in mammals has been granted Patent No.
- Osteoarthritis Diet: Foods to Eat and Avoidon November 10, 2019 at 7:25 am
If you have osteoarthritis, then you know how much joint pain can affect your daily life. Osteoarthritis is the most common type of arthritis, afflicting more than 30 million adults across the U.S., ...
via Google News and Bing News